BioRestorative Therapies, Inc. (BRTX)
USD 1.41
(-9.03%)
USD 1.41
(-9.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 145.8 Thousand | 119.8 Thousand | 46 Thousand | 77 Thousand | 130 Thousand | 111 Thousand |
| Cost of Revenue | - | 280.66 Thousand | 205.2 Thousand | - | - | - |
| Gross Profit | 145.8 Thousand | -160.86 Thousand | -159.2 Thousand | 77 Thousand | 130 Thousand | 111 Thousand |
| Operating Expenses | 15.36 Million | 18.98 Million | 26.35 Million | 2.82 Million | 8.56 Million | 7.75 Million |
| Selling, General and Administrative Expenses | 11.33 Million | 15.58 Million | 25.62 Million | 1.95 Million | 6.83 Million | 6.24 Million |
| Research and Development Expenses | 4.03 Million | 3.51 Million | 729.05 Thousand | 876.82 Thousand | 1.72 Million | 1.51 Million |
| Other Expenses | - | -110.51 Thousand | -16.18 Million | -658.15 Thousand | -1.86 Million | -1.41 Million |
| Cost and Expenses | 15.36 Million | 18.98 Million | 26.35 Million | 2.82 Million | 8.56 Million | 7.75 Million |
| Operating Income | -15.22 Million | -18.97 Million | -26.3 Million | -2.75 Million | -8.43 Million | -7.64 Million |
| Interest Expense | - | 11.65 Thousand | 1.81 Million | 1.64 Million | 5.13 Million | 3.22 Million |
| Income Tax Expense | - | -479.25 Thousand | -14.36 Million | 981.99 Thousand | 3.27 Million | -1.64 Million |
| Earnings before Tax | -10.41 Million | -18.49 Million | -44.3 Million | -11.27 Million | -14.64 Million | -12.51 Million |
| Net Income | -10.41 Million | -18.01 Million | -29.93 Million | -12.25 Million | -17.92 Million | -12.51 Million |
| Earnings Per Share Basic | -2.47 | -4.98 | -25.21 | -31.05 | -3217.82 | -4269.37 |
| Earnings Per Share Diluted | -2.47 | -4.98 | -25.21 | -31.05 | -3217.82 | -4269.37 |
| Weighted Average Shares Outstanding | 4.21 Million | 3.61 Million | 1.18 Million | 394.7 Thousand | 5569.34 | 2932.00 |
| Weighted Average Shares Outstanding (Diluted) | 4.21 Million | 3.61 Million | 1.18 Million | 394.7 Thousand | 5569.34 | 2932.00 |
| Gross Margin | 1.00 | -1.34 | -3.46 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -103.26 | -158.54 | -921.71 | -42.71 | -77.54 | -79.49 |
| Profit Margin | -71.45 | -150.38 | -650.84 | -159.15 | -137.85 | -112.77 |
| EBITDA | -15.05 Million | -18.85 Million | -26.21 Million | -9.48 Million | -9.29 Million | -9.05 Million |
| Earnings Before Tax Margin | -104.39 | -158.38 | -571.91 | -35.74 | -64.86 | -68.90 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 89.1 Thousand | 35 Thousand | 19.3 Thousand | 145.8 Thousand | 30.7 Thousand | 64.5 Thousand |
| Cost of Revenue | 54.19 Thousand | 42.71 Thousand | 42.71 Thousand | 165.73 Thousand | 42.14 Thousand | 70.53 Thousand |
| Gross Profit | 34.9 Thousand | -7713.00 | -23.41 Thousand | -19.93 Thousand | -11.44 Thousand | -6037.00 |
| Operating Expenses | 2.5 Million | 4.1 Million | 3.19 Million | 15.2 Million | 3.13 Million | 3.18 Million |
| Selling, General and Administrative Expenses | 1.21 Million | 3.04 Million | 2.51 Million | - | 2.26 Million | 2.21 Million |
| Research and Development Expenses | 1.29 Million | 1.05 Million | 680.63 Thousand | - | 874.82 Thousand | 967.89 Thousand |
| Other Expenses | -1.73 Million | 149.02 Thousand | -150.42 Thousand | - | 33.95 Thousand | 39.81 Thousand |
| Cost and Expenses | 2.55 Million | 4.14 Million | 3.23 Million | 15.36 Million | 3.13 Million | 3.18 Million |
| Operating Income | -2.46 Million | -4.1 Million | -3.22 Million | -15.22 Million | -3.1 Million | -3.11 Million |
| Interest Expense | - | - | 176.07 Thousand | - | -61.66 Thousand | -96.18 Thousand |
| Income Tax Expense | 5.00 | -3.00 | -3.00 | -5.00 | -42.14 Thousand | -96.18 Thousand |
| Earnings before Tax | -4.02 Million | -2.22 Million | 1.17 Million | -10.41 Million | -83.33 Thousand | -2.98 Million |
| Net Income | -4.02 Million | -2.22 Million | 1.17 Million | -10.41 Million | -83.33 Thousand | -2.98 Million |
| Earnings Per Share Basic | -0.50 | -0.33 | 0.25 | - | -0.02 | -0.77 |
| Earnings Per Share Diluted | -0.50 | -0.33 | 0.25 | - | -0.02 | -0.77 |
| Weighted Average Shares Outstanding | 8.12 Million | 6.67 Million | 4.7 Million | 4.21 Million | 4.57 Million | 3.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.12 Million | 6.67 Million | 4.7 Million | 4.21 Million | 4.57 Million | 3.88 Million |
| Gross Margin | 0.39 | -0.22 | -1.21 | -0.14 | -0.37 | -0.09 |
| EBIT Margin | -27.17 | -116.19 | -164.66 | - | -101.12 | -47.67 |
| Profit Margin | -45.21 | -63.52 | 60.75 | -71.45 | -2.71 | -46.21 |
| EBITDA | -2.42 Million | -4.06 Million | -3.17 Million | - | -3.1 Million | -3.07 Million |
| Earnings Before Tax Margin | -27.71 | -117.41 | -166.87 | -104.39 | -101.12 | -48.32 |
WBTN
KURRF
VRSEF
TEPCY
688233
SNTI